...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Crazy Question
4
Jan 05, 2024 09:37AM
2
Jan 05, 2024 01:34PM
2
Jan 05, 2024 01:44PM

Fuzzyjr wrote;

"As far eversana goes - is it confidential as they prepare to take rvx to court over the overwhelming debt? Last we heard eversana was sitting on the bench/sidelined, right? If not rvx might have been or still racking up an even larger debt to them?"

So mark your calendars : May 13, 2024

From RVX website:

RESVERLOGIX ANNOUNCES ONE-YEAR EXTENSION OF DEBENTURE

March 20, 2023

CALGARY, Alberta, March 20, 2023 - Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0 million secured convertible debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink"), and payment of accrued interest thereon, extending the maturity date to May 13, 2024. In connection with the extension, the interest rate was amended from 10% to 12% per annum, commencing on May 14, 2023.

So who will be the first one to eat?   

Time to Ch$t or get off the pot!

Long.

 


Jan 05, 2024 03:34PM
1
Jan 05, 2024 04:37PM

Jan 05, 2024 04:43PM
7
Jan 06, 2024 10:12AM
2
Jan 06, 2024 01:10PM
Share
New Message
Please login to post a reply